We pull official government recall records and translate each one into plain language: what happened, how serious it is, and the steps to take. No legalese.
Search by meaning, not just keywords — describe the product or the hazard and we’ll find matching recalls even when the official notice uses different words. Brand names and model numbers work too.
Boothwyn Pharmacy recalls Semaglutide 2.5 mg/mL injections with subpotent drug risk. Affected units have batch codes 03202025@2, @3, @4 and expiration 07/18/2025. No remedy specified in official notice.
Ascend Laboratories recalls 5mg rizatriptan tablets due to potential N-nitroso-dimethyl-rizatriptan impurity above FDA limits. Affected lots manufactured in India, distributed in US. No remedy specified.
Strides Pharma recalls 90mg Cinacalcet tablets with failed dissolution specs. Rx-only bottles may not work as intended. Check NDC 64380-885-04 and lot 7715893A for affected units.
Boothwyn Pharmacy recalls Semaglutide 2.5 mg/mL injection (2mL) due to subpotent drug levels. Affected lots: 03202025@5-8, batched until July 2025. No specific remedy stated in recall notice.
Imprimis NJOF recalls epinephrine vials with subpotent assay results from stability testing. These vials may not contain enough active ingredient for effective treatment. Contact for details.
